E Fund Management Co. Ltd. Acquires New Position in Astera Labs, Inc. $ALAB

E Fund Management Co. Ltd. purchased a new stake in Astera Labs, Inc. (NASDAQ:ALAB) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 196,877 shares of the company’s stock, valued at approximately $95,096,000. Astera Labs comprises about 2.1% of E Fund Management Co. Ltd.’s investment portfolio, making the stock its 14th biggest position.

Several other large investors also recently added to or reduced their stakes in ALAB. Johnson Financial Group Inc. acquired a new position in shares of Astera Labs during the 2nd quarter valued at about $43,000. Bell Investment Advisors Inc acquired a new stake in Astera Labs during the second quarter worth about $43,000. Reflection Asset Management acquired a new stake in Astera Labs during the fourth quarter worth about $25,000. Trifecta Capital Advisors LLC purchased a new position in Astera Labs during the second quarter worth about $79,000. Finally, CX Institutional raised its stake in Astera Labs by 1,330.8% during the second quarter. CX Institutional now owns 186 shares of the company’s stock worth $90,000 after purchasing an additional 173 shares during the period. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several brokerages recently weighed in on ALAB. Jefferies Financial Group increased their price objective on Astera Labs from $270.00 to $450.00 and gave the stock a “buy” rating in a research report on Wednesday, August 5th. JPMorgan Chase & Co. lifted their target price on Astera Labs from $205.00 to $280.00 and gave the company an “overweight” rating in a research report on Wednesday, May 6th. Stifel Nicolaus upped their price target on Astera Labs from $260.00 to $460.00 and gave the company a “buy” rating in a research note on Wednesday, June 24th. Evercore reiterated an “outperform” rating and set a $297.00 price target on shares of Astera Labs in a report on Tuesday, May 19th. Finally, Morgan Stanley raised their price objective on Astera Labs to $335.00 and gave the stock an “overweight” rating in a research report on Monday, August 3rd. One research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and eight have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $333.00.

Insider Activity

In other news, Director Stefan A. Dyckerhoff sold 8,994 shares of the company’s stock in a transaction dated Wednesday, July 1st. The stock was sold at an average price of $450.00, for a total transaction of $4,047,300.00. Following the completion of the transaction, the director directly owned 4,631 shares of the company’s stock, valued at approximately $2,083,950. This represents a 66.01% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, COO Sanjay Gajendra sold 90,630 shares of the company’s stock in a transaction that occurred on Monday, August 17th. The shares were sold at an average price of $340.35, for a total value of $30,845,920.50. Following the completion of the transaction, the chief operating officer directly owned 1,119,038 shares of the company’s stock, valued at $380,864,583.30. This trade represents a 7.49% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. In the last quarter, insiders have sold 419,244 shares of company stock valued at $163,135,169. Insiders own 10.40% of the company’s stock.

Trending Headlines about Astera Labs

Here are the key news stories impacting Astera Labs this week:

• Positive Sentiment: Analyst upgrade: Northland Securities raised Astera Labs to “Outperform,” supporting the bullish case for the stock. Northland Securities Upgrades Astera Labs to Outperform
• Positive Sentiment: AI connectivity demand: Coverage highlights record demand for Astera Labs’ connectivity products as AI data-center infrastructure expands. The company’s recent results reinforce that trend, with revenue up 104.5% year over year and earnings exceeding analyst expectations.
• Positive Sentiment: Strong growth profile: Astera Labs has posted accelerating quarterly revenue growth, while rising earnings estimates and demand for AI connectivity make it appear attractive relative to Broadcom in one comparison. ALAB vs. AVGO: Which AI Infrastructure Stock Is the Better Buy Now?
• Positive Sentiment: Platform expansion: Analysts argue Astera Labs is evolving beyond individual components into a broader AI-fabric platform, potentially increasing content per accelerator, customer stickiness and margins. Astera Labs: A Platform Getting Paid Like A Part
• Neutral Sentiment: Insider transactions: CEO Jitendra Mohan, COO Sanjay Gajendra and General Counsel Philip Mazzara sold shares worth roughly $64 million combined. The filings state the sales were made to cover tax withholding on vested equity awards, making them less concerning than discretionary sales, though they may still weigh on sentiment. SEC insider transaction filing
• Negative Sentiment: High valuation and volatility: With a price-to-earnings ratio above 140 and shares trading below their 50-day moving average, investors may be taking profits or reducing exposure despite strong fundamentals. The stock’s elevated beta also increases sensitivity to market and AI-sector sentiment.

Astera Labs Price Performance

Shares of Astera Labs stock opened at $289.02 on Thursday. The business has a 50-day moving average of $355.88 and a 200 day moving average of $243.65. Astera Labs, Inc. has a 12 month low of $97.89 and a 12 month high of $499.48. The stock has a market capitalization of $50.14 billion, a price-to-earnings ratio of 143.08 and a beta of 3.84.

Astera Labs (NASDAQ:ALAB) last issued its quarterly earnings results on Tuesday, August 4th. The company reported $0.80 EPS for the quarter, beating the consensus estimate of $0.69 by $0.11. Astera Labs had a net margin of 30.74% and a return on equity of 19.24%. The company had revenue of $392.40 million during the quarter, compared to analysts’ expectations of $360.85 million. During the same quarter last year, the company posted $0.44 EPS. The firm’s revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. Equities research analysts anticipate that Astera Labs, Inc. will post 2.7 earnings per share for the current year.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.